Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

How Has The Acute Kidney Injury Market Size Shifted, And What Is the Outlook Through 2034?

In the past few years, the acute kidney injury market has experienced robust growth. The market, which is valued at $5.37 billion in 2024, is projected to rise to $5.74 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%. This steady growth during the historic period can be attributed to several factors. These include the growing number of chronic diseases, an upward trend in the elderly population, a rise in hospital-acquired infections, heightened awareness regarding kidney health, and advancements in the field of critical care medicine.

The market size for acute kidney injury is slated for substantial growth in the coming years, with projections pointing to $7.39 billion by 2029, encapsulating a compound annual growth rate (CAGR) of 6.5%. The predicted growth during the forecast period can be linked to factors such as rising incidences of sepsis, escalating demand for personalized treatments, increased government initiatives in healthcare, expanding healthcare expenditures in emerging markets, and an intense focus on individualized medicine and regenerative therapies. The forecast period is likely to see trending advancements include wearable dialysis devices, the integration of artificial intelligence in optimizing treatment, portable systems for renal replacement therapy, continuous renal replacement therapy (CRRT) developments, and the integration of remote monitoring and telemedicine.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21079&type=smp

Which Primay Drivers Are Accelerating Growth in the Acute Kidney Injury Market?

The acute kidney injury market is expected to experience an upward trajectory, primarily attributed to the expanding prevalence of diabetes. Diabetes is a collective term for metabolic conditions associated with high sugar levels in the blood. It occurs either due to inadequate insulin production in the body or cells’ failure to react correctly to this hormone. The rising incidence of diabetes can be linked with factors like increasing obesity, unhealthy eating habits, inactive lifestyles, older populations, and advancements in disease awareness and diagnosis. Acute kidney injury sets off metabolic and inflammatory alterations that could potentially affect insulin resistance and glucose balance, emphasizing a sophisticated interaction that could carry implications for diabetes development and treatment. As an example, data from the Office for Health Improvement & Disparities, a government department based in the UK, showed that between March 2022 and March 2023, the proportion of individuals undergoing all eight suggested care processes for type 1 diabetes grew by 22%, while the same for type 2 diabetes increased by 21%. Concurrently, the proportion reaching the target HbA1c levels escalated to 37.9%, as per the National Diabetes Audit (NDA), marking a record high. Thus, the expanding prevalence of diabetes is accelerating the growth of the acute kidney injury market.

Which Primary Segments of the Acute Kidney Injury Market Are Driving Growth and Industry Transformations?

The acute kidney injury market covered in this report is segmented –

1) By Injury: Pre-Renal Kidney Injury, Post-Renal Kidney Injury, Intrinsic Kidney Injury

2) By Treatment Type: Dialysis, Drug Therapy, Urinary Implants

3) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Pre-Renal Kidney Injury: Hypovolemia, Heart Failure-Related Injury, Sepsis-Induced Injury, Renal Artery Stenosis, Hepatorenal Syndrome

2) By Post-Renal Kidney Injury: Ureteral Obstruction, Bladder Outlet Obstruction, Prostate Enlargement (Benign Prostatic Hyperplasia), Kidney Stones, Tumors Affecting Urinary Tract

3) By Intrinsic Kidney Injury: Acute Tubular Necrosis (ATN), Acute Interstitial Nephritis (AIN), Glomerulonephritis, Vasculitis, Rhabdomyolysis-Induced Injury

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=21079&type=smp

Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Acute Kidney Injury Market?# Market?

North America was the largest region in the acute kidney injury market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute kidney injury market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Technological Trends Are Reshaping the Acute Kidney Injury Industry Dynamics?

Mainstream businesses active in the acute kidney injury (AKI) sector are striving to secure regulatory permissions to upgrade their product catalogue and propose innovative treatment alternatives. These permissions are formal certifications provided by authoritative agencies like FDA or EMA, permitting a product’s marketing and sale upon successful meeting of efficiency, safety, and quality benchmarks. For instance, in December 2023, Mission Therapeutics Ltd., a biotech firm headquartered in the UK, obtained FDA’s permission for the commencement of a Phase II clinical experiment for its primary asset, MTX652, aimed at acute kidney injury (AKI) in patients exposed to high risk post-cardiac surgery. It has been formulated to target key pathways associated with kidney harm and repair, with an intention to curb inflammation, ward off additional kidney damage and facilitate recovery. A standout feature of this trial is its emphasis on deploying new therapeutic strategies to tackle the fundamental molecular sources of AKI, which could present superior treatment alternatives compared to the current interventions. The Phase II trial will study MTX652’s safety, effectiveness, and pharmacokinetics, offering essential information that may encourage wider clinical usage and prospective endorsement.

View the full report here:

https://www.thebusinessresearchcompany.com/report/acute-kidney-injury-global-market-report

What Parameters Are Used to Define the Acute Kidney Injury Market?

Acute kidney injury (AKI) refers to a sudden decline in kidney function, leading to an accumulation of waste products, electrolytes, and fluids in the body. It can develop rapidly over hours or days and is often caused by conditions like reduced blood flow, direct kidney damage, or obstruction of the urinary tract.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21079

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model